A Clinical Study to Determine Whether an Investigational Medication (SEP-363856) Changes How Long it Takes for Food to Move Through the Stomach Into the Small Intestine in Patients With Schizophrenia. The Study Will Help to Understand Any Effect SEP-363856 May Have on Blood Sugar Levels After a Meal
Condition: Schizophrenia Interventions: Drug: SEP-363856; Drug: Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole) Sponsor: Sunovion Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abilify | Research | Risperdal Consta | Schizophrenia | Seroquel | Study | Sugar | Zyprexa